Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It will be hard enough to put one new member on the board, a slate of new board

Yes back in 2004 it MAY have been a qualifying event. But, each and every event that is just like it may not be.

We have had this happen before therefore it is now a 'routine' event.

The reporting of it to the SEC is (to me) a non event and will not help us at all. It's just not significant.

\Much ado about nothing IMO

Share
New Message
Please login to post a reply